| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $508.2M | — | +16.8% |
| Cost of Revenue | $351.6M | — | +208.6% |
| Gross Profit | $156.6M | — | -51.2% |
| R&D Expense | $254.4M | — | +15.3% |
| SG&A Expense | $58.2M | — | -12.3% |
| Operating Income | -$351.4M | — | -174.7% |
| Pre-tax Income | -$354.0M | — | -367.5% |
| Income Tax | -$7.0M | — | -421.3% |
| Net Income | -$347.6M | — | -347.7% |
| EPS (Basic) | -$0.80 | — | -321.1% |
| EPS (Diluted) | -$0.80 | — | -321.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.14B | +4.1% | +38.9% |
| Accounts Receivable | $654.0M | +1.6% | +18.3% |
| Current Assets | $2.92B | +3.9% | +30.6% |
| Total Assets | $6.52B | -4.6% | -1.9% |
| Current Liabilities | $1.50B | -1.6% | +83.6% |
| Total Liabilities | $3.28B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $71.3M | — | +447.3% |
| Capital Expenditures | $4.8M | — | -15.5% |
| Investing Cash Flow | -$4.8M | — | +15.5% |
| Financing Cash Flow | $11.6M | — | -4.9% |
| Free Cash Flow | $66.5M | — | +809.4% |
| +1.9% |
| Stockholders' Equity | $2.98B | -8.1% | -6.6% |